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The investigation of metabolic regulation at the transcriptional level presents different challenges than those
encountered in the study of other important problems like development or cancer. Levels of key components
like glucose, insulin, and lipids can be modulated but rarely change in an all-or-none fashion, necessitating
quantitative techniques that can be applied to multiple tissues and systems. This review examines recent
advances in methods for studying transcriptional regulation, with special emphasis on metabolic science.
We compare these methods for investigators trying to decide on the best approach for their particular phys-
iological paradigm or model system.Identifying Transcriptional Regulators through
Expression Analysis
The transcriptional components that drive the development and
function of metabolically active cell types are often themselves
controlled at the level of gene expression. Identifying such tran-
scription factors (TFs) that are regulated in a spatial and temporal
manner represents an important approach. However, discov-
ering these factors has remained challenging to investigators
of energy metabolism, since relatively small changes in TF
gene expression can have significant biological effects. Below
we discuss classic and more modern expression profiling
methods, highlighting those quantitative methods we believe
are most appropriate to facilitate the discovery of differentially
expressed transcriptional regulatory proteins involved in meta-
bolic programs.
High-Throughput Analysis of Whole Transcriptomes
Differentially expressed transcriptional components can be
identified using high-throughput expression methods that eluci-
date cellular mRNA profiles. Historically, this includes subtrac-
tive hybridization techniques, such as those employed in the
discovery of the myogenic transcription factors MyoD and
Pax7 (Davis et al., 1987; Seale et al., 2000), and microarray tech-
nology, which has been the most commonly used approach of
the last decade. Microarray analyses have been successful in
uncovering many novel transcriptional regulators of metabolism,
including factors involved in the development and function of the
endocrine pancreas and adipose tissue (Chen et al., 2005; Gun-
ton et al., 2005; Smith et al., 2010; Soyer et al., 2010). There are,
however, significant limitations to the microarray approach.
Perhaps the most important is the limited sensitivity to detect
signals accurately when expression levels are low; since tran-
scriptional components can be expressed at low levels and still
exert important actions, this is a serious concern. High back-
ground levels, due to nonspecific binding to hybridization
probes, as well as the tendency for saturation of signals, create
a relatively small dynamic range for quantitative analysis of gene
expression (Okoniewski andMiller, 2006). Thus, identifying thosecritical regulators expressed only at low levels and/or those
important factors whose expression changes only modestly
can be challenging with this technology.
The introduction of high-throughput ‘‘next-generation’’
sequencing technologies over past few years has begun to revo-
lutionize gene expression analyses. ‘‘RNA-Seq’’ is a recently
developed approach that utilizes deep-sequencing technology
for complete transcriptome profiling. In general, this approach
involves the conversion of RNA into cDNA fragments containing
adaptors that allow for sequencing. RNA-Seq is proving to be
a highly sensitive and quantitative method for expression anal-
ysis (Wang et al., 2009). Importantly, this method is unbiased,
since it can quantify both known and unknown isoforms and
transcripts for a given mRNA (Ozsolak and Milos, 2011). In the
near future, this method has the potential to replace all current
genome-wide expression profiling techniques.
DirectedGenome-wide Analyses of Transcription Factor
Gene Expression
The sequencing and annotation of whole mammalian genomes
have allowed for more focused analyses of gene regulation.
Direct analysis of transcriptional components offers significant
advantages over whole transcriptome profiling for identifying
transcriptional components on the basis of differential expres-
sion (Table 1). In particular, direct profiling eliminates the need
to utilize bioinformatic tools to filter through large microarray or
deep-sequencing data sets to identify potential transcriptional
components. Transcriptional cascades involving members of
the nuclear hormone receptor family were elucidated through
quantitative PCR analysis of nuclear receptor gene expression
across multiple murine tissues (Bookout et al., 2006; Gofflot
et al., 2007). In 2004, Gray et al. compiled a catalog of murine
transcriptional components that includes all known TFs and all
proteins that contain a motif that has been associated with tran-
scriptional components, whether their function was known or not
(Gray et al., 2004). This catalog appears to be rather comprehen-
sive, containing both known and suspected transcriptional regu-
lators. In situ hybridization probes generated with primersCell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 739
Table 1. Comparison of Approaches to Identify Transcriptional Components
Identifying TFs through Expression Profiling
Method Pros Cons
Gene expression arrays Technology and analysis tools very
widespread; non-TF target genes can be
assessed in concert with TF genes
Small dynamic range for quantitative analysis
of gene expression; low sensitivity; limited
to known transcripts
qPCR(Quanttrx) Real-time PCR technology available to most
molecular labs; data easy to analyze; very
sensitive; quantitative over wide range of
expression; highly reproducible; direct analysis
of TFs
Limited to predefined list of TFs and isoforms
Sequencing(RNA-Seq) Very sensitive; quantitative over wide dynamic
range; identifies all known and unknown
transcripts; non-TF target genes can be
assessed in concert with TF genes
Technology and analysis methods not yet
widespread; large data sets require
bioinformatics expertise
NanoString Very sensitive; quantitative over wide range
of expression; high-throughput; direct analysis
of TFs
Technology not currently widespread; requires
upfront investment in specialized equipment;
limited to predefined list of TFs and isoforms
Identifying TFs through Analysis of cis-Regulatory Regions
Method Pros Cons
DNase-Seq Increased sequencing depth can reveal
‘‘footprinted’’ motifs; requires less starting
material than ChIP-Seq
Does not distinguish between enhancers,
promoters, or other regulatory elements;
optimization can be troublesome; cost of deep
sequencing is high (but declining); does not
immediately reveal relevant TF involved;
requirement for significant downstream
analysis at genome-wide level
FAIRE-Seq Technically simple; requires less starting
material than ChIP-Seq
Does not distinguish between enhancers,
promoters, or other regulatory elements; cost
of deep sequencing is high (but declining); does
not immediately reveal relevant TF involved;
requirement for significant downstream
analysis at genome-wide level
ChIP-seq of modified histone marks Can identify enhancers specifically, and can
distinguish between poised and active
enhancers
Can require significant amounts of starting
material (>106 cells per epitope); need for
high-quality antibody; cost of deep sequencing
is high (but declining); does not immediately
reveal relevant TF involved; requirement for
significant downstream analysis at
genome-wide level
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regulators have been used to derive a relatively complete atlas of
TF gene expression in the murine brain and developing
pancreas; this has resulted in the identification of novel regula-
tors of glial and pancreatic endocrine development (Fu et al.,
2009; Zhou et al., 2007). The validated primers used to amplify
these genes have also been utilized for genome-wide RT-PCR
analysis of transcriptional components in other developing
murine tissues, leading to the discovery of novel regulators of
gastrointestinal and brown adipose tissue development (Choi
et al., 2006; Seale et al., 2007).
We have recently modified and improved the methodology for
direct expression analysis of transcriptional components by
building a high-throughput platform for quantitative real-time
PCR (Gupta et al., 2010). This was achieved by redesigning
and synthesizing new primers to the list of transcriptional
components described by Gray and colleagues, to render
them suitable for real-time PCR analysis. Importantly, we740 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.included primers that amplify transcriptional coregulators; this
provides a method to identify DNA-binding transcription factors
as well as non-DNA-binding proteins. The conversion of the ex-
isting Gray et al. platform to a quantitative PCR screen is signif-
icant, since, as described above, quantitative biological traits
may be driven by small differences in TF gene expression. It is
especially relevant for metabolic pathways, since these are often
under quantitative rather than qualitative control.
This high-throughput real-time PCR platform for direct quanti-
tative expression analysis of murine transcriptional components,
termed Quanttrx, has been used to uncover novel transcriptional
networks in energy metabolism. For example, it was used to
explore the transcriptional basis of preadipocyte commitment,
identifying the C2H2 zinc finger protein Zfp423, as a preadipo-
cyte-enriched factor required for the regulation of PPARg and
adipocyte development (Gupta et al., 2010). Quanttrx also aided
in the discovery of several novel transcriptional pathways
controlling the physiological response of murine muscle to
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latory cascade that mediates the PGC-1a-dependent fiber type
switch in skeletal muscle (Rasbach et al., 2010) as well as the
identification of C/EBPb as a repressor of cardiomyocyte hyper-
trophy and proliferation (Bostrom et al., 2010).
Limitations of Current Methods and Future Prospects
There are important limitations to all of the approaches
described above (Table 1). First and foremost, the use of any
form of expression profiling to identify transcriptional regulators
relies on the assumption that such regulators are themselves
controlled at the level of gene expression. Importantly, microar-
rays, in situ hybridization, and PCR are all hybridization-based
techniques. Thus, nonspecific binding or crossreactivity can
create both false-positive and false-negative results. Many
genes encode multiple isoforms of gene products, many of
which have yet to be identified. It is also likely that neither our
current database of transcriptional components nor the tran-
scriptome coverage of existing arrays is truly complete. RNA-
Seq can overcome these limitations; however, before other
methods become obsolete, the costs of individual experiments
and equipment required to execute this technology will likely
have to be reduced. Importantly, the expertise to carry out the
analysis of such large data sets will also need to become more
widespread.
In the future, gene expression profiling techniques will
continue to rapidly evolve. One interesting prospect for direct
profiling of TFs is the conversion of Quanttrx to NanoString.
This technology allows for the direct quantitative measurement
of mRNA levels without enzymatic reaction but at the sensitivity
level of quantitative PCR (Geiss et al., 2008). Importantly, the
NanoString system can measure up to 800 transcripts at one
time, significantly reducing the time needed for experiments.
Inferring and Identifying Transcriptional Components
through Analysis of cis-Regulatory Regions
Wehave describedmethods for identifying TFs and coregulators
via the direct measurement of their mRNA levels. There are
instances, however, in which the activity of a TF changes without
being reflected in the expression level of the factor itself. For
example, many TFs exist in the cell in a ‘‘poised’’ state, ready
to be activated by environmental changes. NFkB, SREBP2,
and FoxO factors are examples of TFs with metabolic actions
that shuttle between the nucleus and the cytoplasm depending
upon nutritional and/or inflammatory signals (Goldstein et al.,
2006; Van Der Heide et al., 2004). For such factors, determina-
tion of mRNA expression alonewould not yield information about
involvement in a particular pathway.
This problem can be circumvented by studying the DNA itself,
with an eye toward finding regions that mediate key regulatory
events. Once an important regulatory region has been identified,
one can often infer transcriptional pathways by motif analysis.
Alternatively, the sequence can serve as bait in a protein-binding
assay. This is not a new idea, of course. For decades, ‘‘promoter
bashing’’ techniques have been used to locate regulatory
regions. Indeed, functional analysis of the Fabp4 (also called
aP2) promoter led to the identification of the first fat-selective
enhancer (Graves et al., 1992) and ultimately to the identification
of PPARg as a master regulator of fat cell development (Tonto-
noz et al., 1994).There are two major problems with these approaches, as they
have been traditionally applied. One is that it is necessary to
predefine regions to focus on, such as promoters. These regions
may be enriched for certain types of cis elements, but other
regions of potential importance are ignored a priori. Second,
these methods are very time and labor intensive. Fortunately,
recent advances now allow researchers to query the entire
genome quickly as they search for important regulatory
sequences.
New techniques for identifying regulatory sequences in an
unbiased fashion include computational approaches, as well
as experimental strategies such as DNase hypersensitivity and
location analysis of modified histones or TFs using chromatin
immunoprecipitation. These can be followed either by hybridiza-
tion to an array (ChIP-chip) or, more commonly, massively
parallel sequencing (ChIP-Seq).
Computational Approaches
A large number of algorithms have been developed to identify
potential TF-binding sites in the genome from sequence informa-
tion. These methods either search for all examples of known
motifs corresponding to specific cognate TFs, or they identify
overrepresented motifs that may not yet be associated with
a specific binding partner. The latter utilizes hidden Markov
models, expectation-maximization, Gibbs sampling, or other
approaches (Das and Dai, 2007; Elnitski et al., 2006). All of these
strategies can be helpful, but in general they suffer from a lack
of specificity. As one example, we recently identified 40,000
binding sites for PPARg in human adipocytes, compared to
roughly 1.5 million predicted PPARg motifs in the human
genome; others have reported similar results (Lefterova et al.,
2008; Mikkelsen et al., 2010; Nielsen et al., 2008). Although
some of the excess binding sites are likely to be utilized by
PPARg in other cell types or physiological contexts (Lefterova
et al., 2010), it is clear that the identity of a true binding site is
defined by more than just the primary motif sequence. Further-
more, many motifs are shared by multiple TFs; again, nuclear
hormone receptors provide a good example, as the PPARs,
HNF-4s, and RARs bind to very similar DR-1 motifs.
DNA Sequence Conservation as a Discovery Tool. A long-held
tenet of genome biology is that functionally important regions will
be conserved, as mutational drift would presumably be delete-
rious to fitness. This is clearly true for exons and some other
genomic elements, but not as clear for enhancers and other
regulatory elements. For example, only 15%–30% of modified
histone marks were shared between developing murine and
human adipocytes (Mikkelsen et al., 2010). This is also true for
specific TFs: 80% of PPARg-binding sites in mature murine
3T3-L1 adipocytes are not found at the orthologous position in
human adipocytes. This is true of many other factors as well:
FoxA2, C/EBPa, and HNF4a all show a high degree of species
specificity in binding (Schmidt et al., 2010, 2011; Soccio et al.,
2011). Interestingly, while particular binding sites are generally
not well conserved, there is excellent conservation of the genes
regulated by any given TF in different species. Thus, lipid-
handling genes virtually all have PPARg-binding sites in human
and murine adipocytes, though PPARg binds to different places
in each species (Mikkelsen et al., 2010). This does not mean that
conservation is not useful in determining sites of potential TF
interaction; in combination with other parameters (e.g., theCell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc. 741
Cell Metabolism
Technical Reviewpresence of modified histones or open chromatin), it can be
helpful (see below).
Experimental Approaches
A variety of techniques have been employed to identify cis-regu-
latory elements. For the purposes of this review, we will focus on
methods that allow genome-wide assessment of regulatory
elements rather than approaches that focus on specific regions,
such as reporter assays and electrophoretic mobility shift assays
(EMSAs). These latter approaches are still very useful in vali-
dating and fine-mapping individual elements of interest, but
they are not particularly easy to perform on a genome-wide
scale.
DNase HS/FAIRE. Chromatin has a complex and dynamic
tertiary structure that can be more or less accessible to ancillary
factors depending upon how tightly packed it is. In general,
regions that are being actively transcribed or that participate in
the regulation of transcription are ‘‘open,’’ allowing for the rapid
exchange of regulatory factors. The premise of the DNase hyper-
sensitivity technique is that such regions are the first to be
cleaved by small amounts of the nonspecific endonuclease
DNaseI (Krebs and Peterson, 2000). By limiting the amount of
DNaseI or the duration of exposure, cleavage will occur prefer-
entially at spots where the chromatin has loosened, which
include enhancers, promoters, silencers, and locus control
regions. Until recently, detection of such cleavage sites was per-
formed on a gene-by-gene basis using iterative Southern blot-
ting, a cumbersome and difficult technique. An incremental
advance involved the use of QPCR to query multiple sites at
once (Eguchi et al., 2008), but true genome-wide assessment
of DNase hypersensitivity has now been achieved using arrays
(DNase-chip) or deep sequencing (DNase-seq) (Boyle et al.,
2008). These analyses reveal that there are tens of thousands
of hypersensitive sites throughout the genome that vary by cell
type and physiological state, that they correlate well with other
chromatin marks associated with regulatory events (e.g., modi-
fied histones; see below), and that they often confer functional
activity on the appropriate reporter constructs when tested
in vitro (Kharchenko et al., 2011; Stitzel et al., 2010).
There is an additional interesting and attractive feature of
DNase hypersensitivity mapping that has been recently ex-
ploited. DNaseI preferentially cuts open or nonnucleosomal
regions of the genome as described, and typically these regions
are between 400 and 1000 bp in size. Within these regions,
however, are the specific 6–20 bp binding sites utilized by
a variety of TFs. The sequences of these binding sites can be in-
ferred by their relative insensitivity to DNaseI digestion, an obser-
vation that has been used in the past in the method termed
DNase footprinting (Boyle et al., 2011; Hesselberth et al.,
2009). The limiting factor in finding these protected motifs within
hypersensitive regions is sequencing depth; with increased
numbers of reads now being obtained routinely, the opportunity
to identify specific motifs makes hypersensitivity mapping an
attractive option for those seeking to identify novel transcrip-
tional pathways.
Another technique used to map regions that have been
depleted of nucleosomes is Formaldehyde-Assisted Isolation
of Regulatory Elements (FAIRE) (Giresi et al., 2007). Formalde-
hyde is used to crosslink nucleosomes and other chromatin
components to DNA, after which regions with few crosslinks742 Cell Metabolism 14, December 7, 2011 ª2011 Elsevier Inc.can be liberated by shearing. Sequencing these DNA fragments
yields information similar to that of DNase hypersensitivity,
although without the ability to detect specific TF binding motifs.
In a recent study using FAIRE in human islets, 80,000 sites were
identified, including many that were islet specific (Gaulton et al.,
2010). Furthermore, certain noncoding single nucleotide poly-
morphisms (SNPs) associated with type 2 diabetes were located
within these regions, providing a link between regulatory cis
elements and disease risk.
ChIP-Seq. Another way to identify potential regulatory ele-
ments utilizes chromatin immunoprecipitation of modified
histones or other regulatory proteins. DNA is crosslinked to
protein and then sheared, and a specific antibody is used to
precipitate an epitope of interest. Following reversal of crosslink-
ing, the DNA sequences immunoprecipitated with the selected
protein are applied to a genomic array (ChIP-chip) or, more
commonly, subjected to high-throughput sequencing (ChIP-
Seq) (Schones and Zhao, 2008). At first glance, this might
seem to contradict the notion just discussed, that nucleosome
depletion is associated with regions of regulatory importance.
While histones are typically displaced when important transcrip-
tional events occur, those histones that remain in the area, as
well as those on the borders of the depleted zone, are typically
modified. Usually this involves methylation, phosphorylation,
acetylation, or some other posttranslational event, but it can
also involve switching to atypical histone variants, such as
H3.3 or H2A.Z (Bernstein et al., 2007; Schones and Zhao, 2008).
It has recently become clear that the complement of modifica-
tions carried by histone proteins in a given region reflect its func-
tion; i.e., there exists a histone ‘‘code’’ through which one can
infer genomic function if one knows the modifications (Ernst
and Kellis, 2010; Myers et al., 2011). For our purposes, the
most relevant marks relate to enhancer function. Monomethyla-
tion of histone 3 lysine 4 (H3K4me1) is a well-studied enhancer
mark, as is histone 3 lysine 27 acetylation (H3K27Ac). Interest-
ingly, H3K27Ac appears to mark ‘‘active’’ enhancers, while
H3K4me1 marks sites that are both active and poised
(Creyghton et al., 2010). Such poised sites are especially inter-
esting because they may identify sites where transcriptional
regulation may occur in settings other than the one under study,
such as at different developmental stages or under different
nutrient conditions.
A key issue is whether the histone marks that have been tradi-
tionally studied will yield useful information in metabolic studies.
Most published data have centered on characterizing changes in
chromatin state during malignancy or differentiation, processes
characterized by profound changes in gene expression and
phenotype. There have been relatively few studies looking at
how histone marks change during less encompassing events,
such as changes in hormonal status or nutritional state.
However, transient hyperglycemia (16 hr) has been shown to
change H3K4 and H3K9 methylation at specific inflammatory
loci in cultured endothelial cells, and similar changes were
seen in vivo with only 6 hr of hyperglycemia (Brasacchio et al.,
2009; El-Osta et al., 2008). Similarly, fasting affected H3K27
methylation in the hypothalamus of chicks (Xu et al., 2011).
Future studies will undoubtedly compare genome-wide histone
modifications in a variety of situations of metabolic relevance.
It is worth noting that histone modification requires a supply of
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The fascinating connection between metabolic function and
histone modification has been recently reviewed (Teperino
et al., 2010).
Other ‘‘chippable’’ proteins that can yield important informa-
tion about the regulatory state of the genome include RNA poly-
merase (a marker of transcription, obviously), CBP/p300 (which
marks active enhancers), and CTCF (a TF that marks insulator
regions). Finally, of course, once one has identified any specific
transcription factor or cofactor of interest, it is now standard
practice to perform genome-wide ChIP-Seq to determine the
complete cistrome of that factor under conditions of interest.
Integrated Approaches
Although experimental and computational approaches were dis-
cussed separately, the most productive strategies usually
involve combinations of wet lab and in silico techniques. As
mentioned, the major limitation of pure computational motif
finding is the lack of specificity. However, by first performing
some sort of experimental analysis to determine which genomic
regions to focus on,motif finding can be quite productive. As one
example, DNase hypersensitivity analysis was employed to look
at a limited number of genes, and specific loci were identified
that showed differential chromatin accessibility during adipo-
genesis (Eguchi et al., 2008). Motif finding in these DNase hyper-
sensitivity regions identified several motifs belonging to known
adipogenic regulators in addition to motifs that suggested
a role for factors not suspected to pay a role in fat cell develop-
ment. This led to the discovery that interferon regulatory factor 1
(IRF1), IRF3, and IRF4 were antiadipogenic. A more detailed,
genome-wide look at modified histone patterns during murine
and human adipogenesis allowed for a more robust analysis
that led to the identification of thousands of potential differentia-
tion-dependent enhancers (Mikkelsen et al., 2010). Motif finding
within sequences associated with preadipocyte-specific
enhancers led to the prediction that promyelocytic leukemia
zinc finger protein (PLZF, encoded by Zbtb16) and serum
response factor (SRF) might be involved in adipogenesis; subse-
quent experiments showed that both factors are strongly antia-
dipogenic. Others have used modified histone mapping or
DNase-seq to identify cis-regulatory elements that mark tran-
sient, early events in 3T3-L1 differentiation, and then followed
this up with motif finding, leading to the identification of motifs
for RXR, STAT5A/B, C/EBPb, and GR (Siersbaek et al., 2011;
Steger et al., 2010). Efforts continue in many labs to develop
methods that integrate even larger data sets, encompassing
DNase-seq, histone ChIP-seq, motif enrichment, and conserva-
tion to predict novel transcriptional pathways (Pique-Regi et al.,
2011).
It is important to emphasize that all of these approaches are
hypothesis-generating in nature. Identifying an overrepresented
motif in a potential regulatory element does not guarantee that
the cognate TF will play a role in the process under study. There
are many reasons for this. For example, a single motif might be
the target for a family of related TFs; finding the specific isoform
of interest can be difficult. The motif might also predict a TF that
is relevant at a different developmental stage, or in a different
tissue altogether. Finally, many binding sites may not participate
directly in gene expression events (Farnham, 2009). The
meaning of these ‘‘excess’’ sites is currently unclear.In many cases, discovery of a legitimatemotif and its bona fide
binding partner will not tell the whole story, as the activity of a TF
is highly dependent upon posttranslational modifications and
interactions with other members of the enhanceosome,
including coactivators and corepressors that do not directly
contact DNA. Although co-occurring motifs can give some clues
about other TFs that might be involved in the process under
study, the full extent of thesemodifying factors can be discerned
only by careful experimentation.
Conclusions and Future Directions
Each approach to determining transcriptional pathways has
advantages and disadvantages (see Table 1), and the best
chance of success likely lies in the use of some combination of
methods. At present, this can be a costly and time-consuming
proposition, but recent advances may enable streamlining of
this process. For example, the discovery of ‘‘eRNA’’ that marks
active enhancers (Kim et al., 2010; Wang et al., 2011) may signal
a shift toward using RNA-Seq to obtain TF expression data and
information on key cis-regulatory elements in a single assay.
Drugs that directly target TFs are still relatively rare outside of
the agents that act on the nuclear receptor family, but this large
group of compounds gives us some indication of the therapeutic
utility inherent in modulating transcription. Advances in chemical
biology will hopefully demonstrate that there is no theoretical
limit in drug discovery for TFs, which would suggest that
a more complete understanding of the transcriptional pathways
governing the differentiation and physiology of metabolic tissues
will enable targeted therapy of diseases like obesity, type 2 dia-
betes, dyslipidemia, and others. Cancer and aging are other
conditions for which we can be expected to see advances based
in part on discoveries made in the metabolic arena.
In this review we have highlighted some of the new
approaches that currently enable discovery in this area. This is
a fast-moving area, of course, and it is to be expected that there
will be additional refinements in technology, accompanied by
advances in our understanding of how TFs and cofactors regu-
late lipid handling, insulin secretion, nutrient sensing, and other
metabolic processes.
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